Institutional Weekly Chart PackCompleted-week market evidence · Maximum 156 weeks
SAO · Equity · Brazil
N1VS34
Novartis AG
HealthcareDrug Manufacturers - General
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with …
Last updated
31 Jul 2026
Exchange
B3 · SAO
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
BRL
Market capitalisation
1,399,203,823,616
Fair value reference
55.24
Next-week expectancy
Undecided · 52.07%
Executive chart read
Over the latest 12 completed weeks ending 2026-07-31, N1VS34 rose 6.52%, moving from 74.80 to 79.68. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 2 of the last 12 weeks. Relative Strength is 0.44 and has improved across the 12-week window. Market Dynamics is 0.33 on the latest week. Next-week expectancy is undecided at 52.07% based on similar historical setup states.
Week Ending
31 Jul 2026
Latest Close
79.68
12-Week Change
6.52%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 52.07%
Signal Weeks
2 of 12
Weekly Price
Weekly Close
Trend Line
Fair Value
Activity Lines
Chart Panels
Choose up to 5 panels. Drag panel headers to reorder.
Price Action
Up Week
Down Week
Trend Line
Pivotal Level / Support
Volume
Point & Figure
Price structure · volume at price
Point & Figure market structure
Each X marks a rising price box and each O marks a falling price box. Time is removed from the horizontal scale so reversals, breakouts and areas of heavy trading stand out.
MethodAdaptive scale
Smart Money
Close Price
Trend Line
Demand Threshold Line
Reversal Risk Level
Market Dynamics
Volume Action
Price Action
Market Dynamics
Rate of Change
0-1.5TopBottomRawCloseMarket Strength30W ROCVolume SupportPrice Action RibbonBuyFlip UpFlip Down
Price Cycle
Market Price Cycle
PC Activity Line
PC Trend Line
Next-State Map
Next-State Map
Historical one-week transition paths from similar completed-week states.
SMI
Weekly Close
Trend Line
Fair Value
Activity Lines
SMI
Chart Summary
Key Points
Week Ending
31 Jul 2026
Latest Close
79.68
12-Week Change
6.52%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 52.07%
Signal Weeks
2 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
0.44
Market Dynamics
0.33
Over the latest 12 completed weeks ending 2026-07-31, N1VS34 rose 6.52%, moving from 74.80 to 79.68. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 2 of the last 12 weeks. Relative Strength is 0.44 and has improved across the 12-week window. Market Dynamics is 0.33 on the latest week. Next-week expectancy is undecided at 52.07% based on similar historical setup states.
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.